カテゴリ： GlobalData, ドイツ, 企業調査

B. Braun Melsungen AG：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：B. Braun Melsungen AG - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7118
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
B. Braun Melsungen AG (B. Braun) develops, manufactures and distributes medical technology and pharmaceutical products, and provides medical services worldwide. The company’s major products include solutions and disposables for infusion, nutrition and pain therapy, infusion pumps and systems, suture materials, hip and knee implants, surgical instruments, dialysis equipment and accessories, stoma and wound care products. B. Braun provides products and systems for the fields of anesthesia, intensive care, cardiology, extracorporeal blood treatment and surgery, besides services for clinics, physician practices, and the home care segment. The company sells products directly in Europe, the Americas, Asia-Pacific, Africa and the Middle East. B. Braun is headquartered in Melsungen, Germany.

B. Braun Melsungen AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
B. Braun Melsungen AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
B. Braun Melsungen AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
B. Braun Melsungen AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
B. Braun Melsungen AG, Medical Equipment, Deal Details 12
Asset Purchase 12
B. Braun Medical to Acquire Bloodlines Business from NxStage Medical 12
B. Braun Medical Acquires Stoma Care Assets from Stimatix GI 13
Venture Financing 14
Gordian Surgical Raises USD2.3 Million in Financing Round 14
Partnerships 15
Aesculap Forms Joint Venture with Christoph Miethke 15
Christie Medical Enters into Agreement with B. Braun Medical 16
B. Braun Enters into Parntership with Royal Philip 17
B. Braun Interventional Systems Forms Partnership with NuMED 18
ICU Medical Enters into Distribution Agreement with B. Braun Melsungen 19
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 20
Cohera Medical Enters into Distribution Agreement with B. Braun Surgical 21
Kinetic Concepts Enters Into An Agreement With B. Braun Medical For Prontosan 22
B. Braun Medical Enters into Co-Marketing Agreement with RyMed for InVision-Plus 23
B. Braun Medical Forms Joint Venture with CeGaT 24
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 25
Maquet Enters Into Co-Marketing Agreement With Aesculap For OR Integration Solutions 26
Misonix Enters Into Distribution Agreement With B. Braun Medical 27
Osseon Therapeutics Enters Into Co-Marketing Agreement With Aesculap 28
Equity Offering 29
Fidmi Medical Raises USD2 Million in Private Placement 29
ApiFix Raises USD2.8 Million in Private Placement of Shares 30
Asset Transactions 31
DaVita HealthCare To Acquire Dialysis Products From B. Braun Medical 31
Acquisition 32
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 32
B. Braun Avitum Acquires Lauer Membran Wassertechnik 33
B. Braun Medical Acquires Carenalis 34
B. Braun Avitum Acquires 51% Stake in Dialy Ser 35
B. Braun Medical International Acquires 60% Stake In Ventas Paraguayas, Medical Equipment Distributor 36
B. Braun Melsungen Acquires 20% Stake In CeGaT 37
B. Braun Melsungen AG – Key Competitors 38
B. Braun Melsungen AG – Key Employees 39
B. Braun Melsungen AG – Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 44
Recent Developments 45
Strategy And Business Planning 45
Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 45
Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 46
Financial Announcements 47
Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 47
Mar 31, 2017: B. Braun continues its sales and earnings growth 49
Corporate Communications 51
Jul 12, 2018: Personnel Changes in Supervisory and Management Board of Aesculap 51
Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 52
Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 53
Feb 22, 2017: Change in the B. Braun Management Board 54
Product News 55
Sep 12, 2018: B. Braun focused on peripheral intravenous access at AVA 55
Sep 06, 2018: Innovative solutions and exiting entrepreneurs: B. Braun Accelerator Demo Day 56
May 03, 2017: B. Braun Focused on Peripheral Vascular Access & Hazardous Drug Safety at INS 57
Other Significant Developments 58
Sep 04, 2018: B. Braun inaugurates Europe’s most modern production site in Saxony 58
Jun 21, 2018: GS1 Ireland Launches Groundbreaking Global Operating Room Data Collection Study at Arizona Hospital 59
Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 60
Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 61
Feb 15, 2017: B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN’s Clinical Nutrition Week 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
B. Braun Melsungen AG, Medical Equipment, Key Facts, 2017 2
B. Braun Melsungen AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
B. Braun Melsungen AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
B. Braun Melsungen AG, Deals By Market, 2012 to YTD 2018 9
B. Braun Melsungen AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
B. Braun Medical to Acquire Bloodlines Business from NxStage Medical 12
B. Braun Medical Acquires Stoma Care Assets from Stimatix GI 13
Gordian Surgical Raises USD2.3 Million in Financing Round 14
Aesculap Forms Joint Venture with Christoph Miethke 15
Christie Medical Enters into Agreement with B. Braun Medical 16
B. Braun Enters into Parntership with Royal Philip 17
B. Braun Interventional Systems Forms Partnership with NuMED 18
ICU Medical Enters into Distribution Agreement with B. Braun Melsungen 19
Proxy Biomedical Extends Distribution Agreement with B. Braun Surgical 20
Cohera Medical Enters into Distribution Agreement with B. Braun Surgical 21
Kinetic Concepts Enters Into An Agreement With B. Braun Medical For Prontosan 22
B. Braun Medical Enters into Co-Marketing Agreement with RyMed for InVision-Plus 23
B. Braun Medical Forms Joint Venture with CeGaT 24
Yungjin Enters Into Distribution Agreement With B. Braun For Enteral Nutrition Products 25
Maquet Enters Into Co-Marketing Agreement With Aesculap For OR Integration Solutions 26
Misonix Enters Into Distribution Agreement With B. Braun Medical 27
Osseon Therapeutics Enters Into Co-Marketing Agreement With Aesculap 28
Fidmi Medical Raises USD2 Million in Private Placement 29
ApiFix Raises USD2.8 Million in Private Placement of Shares 30
DaVita HealthCare To Acquire Dialysis Products From B. Braun Medical 31
B. Braun Medical Acquires Dismed Pharma and Dismed Criticare 32
B. Braun Avitum Acquires Lauer Membran Wassertechnik 33
B. Braun Medical Acquires Carenalis 34
B. Braun Avitum Acquires 51% Stake in Dialy Ser 35
B. Braun Medical International Acquires 60% Stake In Ventas Paraguayas, Medical Equipment Distributor 36
B. Braun Melsungen Acquires 20% Stake In CeGaT 37
B. Braun Melsungen AG, Key Competitors 38
B. Braun Melsungen AG, Key Employees 39
B. Braun Melsungen AG, Subsidiaries 40
B. Braun Melsungen AG, Joint Venture 44

List of Figures
B. Braun Melsungen AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
B. Braun Melsungen AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
B. Braun Melsungen AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
B. Braun Melsungen AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
B. Braun Melsungen AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[B. Braun Melsungen AG：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • BPCE SA：企業のM&A・事業提携・投資動向
    BPCE SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BPCE SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Yamaha Corporation (7951)：企業の財務・戦略的SWOT分析
    Yamaha Corporation (7951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Iberdrola, S.A.：企業のM&A・事業提携・投資動向
    Iberdrola, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iberdrola, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Rheonix Inc：企業の製品パイプライン分析2018
    Summary Rheonix Inc (Rheonix) is a medical equipment company that develops molecular diagnostic products. The company offers automated and integrated molecular testing device. It develops Rheonix CARD cartridge technology which penetrates molecular testing markets from diagnostics labs to applied ma …
  • Enviva Partners LP (EVA)：企業の財務・戦略的SWOT分析
    Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sprint Bioscience AB (SPRINT)：企業の財務・戦略的SWOT分析
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Philippine Bank Of Communications：企業の戦略・SWOT・財務分析
    Philippine Bank Of Communications - Strategy, SWOT and Corporate Finance Report Summary Philippine Bank Of Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Oxford Biodynamics Plc：企業の製品パイプライン分析2018
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neu …
  • Vygon SA-医療機器分野：企業M&A・提携分析
    Summary Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. It offers products in the areas of paediatrics and neonatology, emergency and intensive care units, anaesthesia, support for post-operative pain relief, vascular a …
  • Atlas Genetics Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • Raytheon Co：企業の戦略・SWOT・財務情報
    Raytheon Co - Strategy, SWOT and Corporate Finance Report Summary Raytheon Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Biofrontera AG (B8F)：企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • IMCD N.V.：企業のM&A・事業提携・投資動向
    IMCD N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IMCD N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Sonivate Medical Inc：医療機器：M&Aディール及び事業提携情報
    Summary Sonivate Medical Inc (Sonivate Medical) is a medical device company that develops and manufactures diagnostic imaging technologies. The company offers dual-plane ultrasound probe, a finger-mounted ultrasound probe that leverages innate human hand eye coordination, which with any ultrasound s …
  • Erste Group Bank AG：企業の戦略・SWOT・財務分析
    Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report Summary Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Flexera Software LLC：企業の戦略的SWOT分析
    Flexera Software LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Octapharma AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy (immune disorders), haematology (coagulation disorders), and critical …
  • Aerpio Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary Aerpio Therapeutics Inc (Aerpio) is a biopharmaceutical company that develops novel monoclonal antibodies and small molecules. The company’s programs include a Tie-2 activator for diabetic macular edema and a hypoxia-inducible factor stabilizer for the treatment of inflammatory bowel disease …
  • Eagle Pharmaceuticals Inc (EGRX)：企業の財務・戦略的SWOT分析
    Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Applied Maths NV：医療機器：M&Aディール及び事業提携情報
    Summary Applied Maths NV (Applied Maths), a subsidiary of bioMerieux SA, is a bioinformatics company that designs, develops and markets bioscience software products. The company offers software products such as bionumerics, gelcompar II, bionumerics server and bionumerics calculation engine. Its bio …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆